Vor Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.About VOR
Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide.
VOR Key Statistics
Stock Snapshot
Vor Biopharma(VOR) stock is priced at $21.40, giving the company a market capitalization of 1.27B. It carries a P/E multiple of -0.26.
On 2026-09-20, Vor Biopharma(VOR) stock traded between a low of $21.23 and a high of $22.00. Shares are currently priced at $21.40, which is +0.8% above the low and -2.7% below the high.
The Vor Biopharma(VOR)'s current trading volume is 3.28M, compared to an average daily volume of 1.2M.
During the past year, Vor Biopharma(VOR) stock moved between $6.50 at its lowest and $49.95 at its peak.
During the past year, Vor Biopharma(VOR) stock moved between $6.50 at its lowest and $49.95 at its peak.
VOR News
Vor Biopharma reported completion of enrollment in UPSTREAM MG, its global Phase 3 registrational trial of telitacicept in generalized myasthenia gravis, and ou...
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.